Gastric cancer (HER2-positive metastatic) - trastuzumab: Royal College of Physicians/NCRI/RCR/ACP/JCCO response

Gastric cancer (HER2-positive metastatic) - trastuzumab: Royal College of Physicians/NCRI/RCR/ACP/JCCO response

Gastric cancer (HER2-positive metastatic) - trastuzumab: Royal College of Physicians/NCRI/RCR/ACP/JCCO response
29 September 2010
(75.91 Kb 22 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 23 September 2015